Polfa Lublin to enjoy access to new sales network following take over

The State Treasury yesterday sold 85% of shares in Polfa Lublin, the largest producer of infusion fluids, syringes and medical equipment used in blood infusion and transfusion. The stake was sold for zl. 36.7 million to a consortium of Spectra Holding, which will receive 51% of the shares and U.S. pharmaceutical company Baxter, which acquired another 34%. "The companies declared they will invest an additional $3.5 million in the enterprise over a five year period. "These amounts do not represent a final total of investment into the Lublin project. The development program envisages increasing sales and exports, as well as launching new products," said Tadeusz Duszynski, the director of Polfa Lublin. The plant will become part of Baxter's European production network and will use its sales network. Polfa Lublin employs 600 and expects to post a net profit of zl. 3.2 million this year. (Rzeczpospolita, p. B4) A.K.